These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37306566)

  • 1. Designing novel peptides for detecting the Omicron variant, specifying SARS-CoV-2, and simultaneously screening coronavirus infections.
    Yazdani Z; Rafiei A; Momenizadeh M; Abediankenari S; Yazdani M; Lagzian M
    J Biomol Struct Dyn; 2024 Jun; 42(9):4759-4768. PubMed ID: 37306566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.
    Liu J; Chandrashekar A; Sellers D; Barrett J; Jacob-Dolan C; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
    Nature; 2022 Mar; 603(7901):493-496. PubMed ID: 35102312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters.
    Trimpert J; Herwig S; Stein J; Vladimirova D; Adler JM; Abdelgawad A; Firsching TC; Thoma T; Sehouli J; Osterrieder K; Gruber AD; Sawitzki B; Sander LE; Cichon G
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.
    Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F
    Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
    PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
    Srivastava VK; Kaushik S; Bhargava G; Jain A; Saxena J; Jyoti A
    Biomed Res Int; 2021; 2021():7251119. PubMed ID: 34651048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.
    Alter G; Yu J; Liu J; Chandrashekar A; Borducchi EN; Tostanoski LH; McMahan K; Jacob-Dolan C; Martinez DR; Chang A; Anioke T; Lifton M; Nkolola J; Stephenson KE; Atyeo C; Shin S; Fields P; Kaplan I; Robins H; Amanat F; Krammer F; Baric RS; Le Gars M; Sadoff J; de Groot AM; Heerwegh D; Struyf F; Douoguih M; van Hoof J; Schuitemaker H; Barouch DH
    Nature; 2021 Aug; 596(7871):268-272. PubMed ID: 34107529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2.
    Bates TA; Weinstein JB; Farley S; Leier HC; Messer WB; Tafesse FG
    Cell Rep; 2021 Feb; 34(7):108737. PubMed ID: 33545052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
    Morgenlander WR; Henson SN; Monaco DR; Chen A; Littlefield K; Bloch EM; Fujimura E; Ruczinski I; Crowley AR; Natarajan H; Butler SE; Weiner JA; Li MZ; Bonny TS; Benner SE; Balagopal A; Sullivan D; Shoham S; Quinn TC; Eshleman SH; Casadevall A; Redd AD; Laeyendecker O; Ackerman ME; Pekosz A; Elledge SJ; Robinson M; Tobian AA; Larman HB
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an
    Kesarwani V; Gupta R; Vetukuri RR; Kushwaha SK; Gandhi S
    Front Immunol; 2021; 12():725240. PubMed ID: 34630400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.
    Yang ZH; Song YL; Pei J; Li SZ; Liu RL; Xiong Y; Wu J; Liu YL; Fan HF; Wu JH; Wang ZJ; Guo J; Meng SL; Chen XQ; Lu J; Shen S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity.
    Kim H; Byun JE; Yoon SR; Koohy H; Jung H; Choi I
    Cell Immunol; 2022 Jan; 371():104454. PubMed ID: 34773897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Smits VAJ; Hernández-Carralero E; Paz-Cabrera MC; Cabrera E; Hernández-Reyes Y; Hernández-Fernaud JR; Gillespie DA; Salido E; Hernández-Porto M; Freire R
    Biochem Biophys Res Commun; 2021 Mar; 543():45-49. PubMed ID: 33515911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.